Grant: Idea to Innovation
University of Toronto
$125,000.00
Synthetic applications of boryl carboxylates
EF 2019-20
Résumé
In the Spring of 2019, we discovered boryl carboxylates (CBA), a new class of molecules with untapped synthetic potential. We subsequently applied for a patent to protect this composition of matter. The CBA technology quickly attracted the attention of Merck and we initiated a collaboration in order to understand the scope of potential applications of this new chemistry. As a result, we recently published a joint paper with Merck in Angewandte Chemie. We also received market assessment funding from NSERC, allowing us to retain the services of Adventus Research. Dr. G. Svoboda of Adventus has carried out a thorough market assessment study. The present I2I application considers the main messages from that report and focuses on the applications that will further de-risk our technology now that it is sufficiently mature. With the help of this report, we now have specific steps to strengthen the commercial value of the CBA technology. These include the development of a range of CBA derivatives as well as the demonstration of superior properties of these molecules in the synthesis of challenging heterocycles. Our partners (Merck, Eurofins Alphora, and MilliporeSigma) are ideally suited to help us broaden patent claims and position this technology closer to licensing.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
545140-2019
Name nom
Yudin, Andrei
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Synthetic applications of boryl carboxylates
Keyword
NSERC
Application summary
In the Spring of 2019, we discovered boryl carboxylates (CBA), a new class of molecules with untapped synthetic potential. We subsequently applied for a patent to protect this composition of matter. The CBA technology quickly attracted the attention of Merck and we initiated a collaboration in order to understand the scope of potential applications of this new chemistry. As a result, we recently published a joint paper with Merck in Angewandte Chemie. We also received market assessment funding from NSERC, allowing us to retain the services of Adventus Research. Dr. G. Svoboda of Adventus has carried out a thorough market assessment study. The present I2I application considers the main messages from that report and focuses on the applications that will further de-risk our technology now that it is sufficiently mature. With the help of this report, we now have specific steps to strengthen the commercial value of the CBA technology. These include the development of a range of CBA derivatives as well as the demonstration of superior properties of these molecules in the synthesis of challenging heterocycles. Our partners (Merck, Eurofins Alphora, and MilliporeSigma) are ideally suited to help us broaden patent claims and position this technology closer to licensing.